混合PET/MRI在非小细胞肺癌(NSCLC)与肺结节中的应用——文献综述
本文系统检索PubMed/MEDLINE、Embase和Cochrane Library,纳入9项研究评估混合PET/MRI在NSCLC分期或肺结节检测中的诊断表现。结果显示PET/MRI在NSCLC术前T和N分期方面较PET/CT无优势,M分期数据过少无法得出结论;对FDG高摄取结节及大于10 mm结节检测率与PET/CT相当,但对小于5 mm非FDG高摄取结节灵敏度低。
要点
- PET/MRI在NSCLC术前T和N分期方面较PET/CT无优势。
- PET/MRI对FDG高摄取结节及大于10 mm结节检测率与PET/CT相当。
- PET/MRI对小于5 mm非FDG高摄取肺结节灵敏度低,PET/CT检出率更高。
核心结论
- PET/MRI在NSCLC的T和N分期方面较PET/CT无优势。
- PET/MRI对FDG高摄取肺结节及大于10 mm结节检测灵敏度与PET/CT相当,但PET/CT对小于5 mm非FDG高摄取肺结节检出率更高。
- 由于MRI对肺部诊断性能低于CT,PET/MRI对各类癌症中肺结节的总体检出率仍低于PET/CT。
研究设计与样本
- 数据来源于在PubMed/MEDLINE、Embase和Cochrane Library进行的系统检索,该检索针对癌症患者的混合PET/MRI,用于此前发表的范围综述(https://doi.org/10.1007/s00259-019-04402-8)。
- 纳入英文和德文、评估混合PET/MRI在癌症患者NSCLC或肺结节检测中诊断性能的研究,不限制发表年份。
- 共识别3138篇出版物,纳入2012至2018年发表的116篇,其中9项研究涉及NSCLC(4项)或肺结节检测(5项)。
主要发现
- PET/MRI在NSCLC术前T和N分期方面较PET/CT无优势。
- M分期数据过少,无法得出结论。
- PET/MRI对FDG高摄取结节及大于10 mm结节的检出率与PET/CT相当,但对小于5 mm非FDG高摄取结节的灵敏度低。
- PET/MRI对各类癌症中肺结节的总体检出率低于PET/CT,因MRI对肺部的诊断性能低于CT。
局限性
- M分期数据过少,无法得出结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of hybrid PET/MRI for clinical staging is growing in several cancer forms and, consequently, PET/MRI has also gained interest in the assessment of non-small cell lung cancer (NSCLC) and lung lesions. However, lung evaluation with PET/MRI is associated with challenges related to technical issues and diagnostic image quality. We, therefore, investigated the published literature on PET/MRI for clinical staging in NSCLC or lung nodule detection specifically addressing diagnostic accuracy and technical issues. METHODS: The data originates from a systematic search performed in PubMed/MEDLINE, Embase, and Cochrane Library on hybrid PET/MRI in patients with cancer for a scoping review published earlier ( https://doi.org/10.1007/s00259-019-04402-8 ). Studies in English and German evaluating the diagnostic performance of hybrid PET/MRI for NSCLC or lung nodule detection in cancer patients were selected. Data reported in peer-reviewed journals without restrictions to year of publication were included. RESULTS: A total of 3138 publications were identified from which 116 published 2012-2018 were included. Of these, nine studies addressed PET/MRI in NSCLC (4) or lung nodule detection (5). Overall, PET/MRI did not provide advantages in preoperative T- and N-staging in NSCLC compared to PET/CT. The data on M-staging were too few for conclusions to be drawn. The lung nodule detection rate of PET/MRI was comparable to that of PET/CT for FDG-avid nodules larger than 10 mm, but the sensitivity of PET/MRI for detection of non-FDG-avid nodules smaller than 5 mm was low. CONCLUSION: PET/MRI did not provide advantages in T- and N-staging of NSCLC compared to PET/CT. PET/MRI had a comparable sensitivity for detection of FDG-avid lung nodules and nodules over 10 mm, but PET/CT yielded a higher detection rate in non FDG-avid lung nodules under 5 mm. With PET/MRI, the overall detection rate for lung nodules in various cancer types remains inferior to that of PET/CT due to the lower diagnostic performance of MRI than CT in the lungs.
引用
- Dahlsgaard-Wallenius SE, Hildebrandt MG, Johansen A, et al. Hybrid PET/MRI in non-small cell lung cancer (NSCLC) and lung nodules-a literature review. Eur J Nucl Med Mol Imaging. 2020. PMID: 32719914. doi:10.1007/s00259-020-04955-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。